Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Search Results

Title:
PHASE 2, multi-center, single arm investigation of HSPPC-96 vaccine with temozolomide in patients with newly diagnosed Glioblastoma Multiforme
Protocol Number:
J11107
Phase:
Phase II
Physician:
Michael Lim
Purpose:
Eligibility:
Patients over the age of 18 with newly diagnosed brain tumors concerning for a high grade astrocytoma /glioma are eligible for enrollment.
Treatment:
Population:
Adult
Last Update
11/25/2014 04:06 AM
 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

 

Cancer Dictionary

NCI Dictionary of Cancer Terms, a resource with more than 6,000 terms related to cancer and medicine.

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer